Omentectomy vs Omental Preservation in Resectable Cancer

Launched by CORPORACION PARC TAULI · Feb 16, 2023

Keywords

ClinConnect Summary

This clinical trial is studying two different surgical approaches for patients with stomach cancer that can be surgically removed (known as resectable gastric cancer). Some doctors believe that removing a certain part of the fatty tissue around the stomach (called the omentum) might help patients survive longer, while others think it might not be necessary for early-stage cancers. The trial will compare two groups: one that will have the omentum removed and another that will keep it intact. Researchers want to find out which approach leads to better outcomes in terms of survival and fewer complications after surgery.

To participate in this trial, patients need to be at least 18 years old and have a specific type of stomach cancer (stages T3-4, which means the cancer has spread but is still removable). Patients who have cancer that has spread too far (stage M1), those who are not healthy enough for surgery, or those whose cancer can be treated with less invasive methods will not be eligible. Though the trial is not yet recruiting participants, it aims to provide valuable insights into the best surgical practices for treating stomach cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Older than 18 years old
• • Resectable gastric cancer
• • Gastric cancer T3-4 N+/- M0
• Exclusion Criteria:
• • M1
• • Non surgical patients for medical status
• • Non resectable gastric cancer during surgery
• • Endoscopic resectable gastric cancer